Restoration Robotics Inc Gets a Buy Rating from Maxim Group

By Jason Carr

Maxim Group analyst Anthony Vendetti assigned a Buy rating to Restoration Robotics Inc (NASDAQ: HAIR) today and set a price target of $8. The company’s shares closed yesterday at $3.13, close to its 52-week low of $3.10.

Vendetti said:

“We believe the company’s ARTAS hair restoration system represents a valuable addition to both hair-loss clinics and general aesthetic practices. The system’s FDA-cleared implantation functionality is expected to launch by the end of 2018, further automating the surgical hair restoration procedure. The company is growing its US salesforce with the goal of increasing domestic system sales and driving increased utilization within existing customers.”

According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 11.1% and a 58.5% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Xtant Medical Holdings, Milestone Scientific, and Viveve Medical Inc.

Restoration Robotics Inc has an analyst consensus of Moderate Buy, with a price target consensus of $9.50.

See today’s analyst top recommended stocks >>

The company has a one-year high of $11.95 and a one-year low of $3.10. Currently, Restoration Robotics Inc has an average volume of 150.1K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Restoration Robotics, Inc. manufactures and develops medical devices for hair transplantation services. It provides artas system, a computer-assisted, physician-controlled system to harvest follicular units directly from the scalp.